- Home
- MSGM vs BIAF Comparison
MSGM vs BIAF Comparison
Compare MSGM & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSGM
- BIAF
- Stock Information
- Founded
- MSGM 2018
- BIAF 2014
- Country
- MSGM United States
- BIAF United States
- Employees
- MSGM N/A
- BIAF N/A
- Industry
- MSGM Computer Software: Prepackaged Software
- BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- MSGM Technology
- BIAF Health Care
- Exchange
- MSGM Nasdaq
- BIAF Nasdaq
- Market Cap
- MSGM 14.0M
- BIAF 13.0M
- IPO Year
- MSGM 2021
- BIAF 2022
- Fundamental
- Price
- MSGM $2.33
- BIAF $2.45
- Analyst Decision
- MSGM
- BIAF Hold
- Analyst Count
- MSGM 0
- BIAF 1
- Target Price
- MSGM N/A
- BIAF N/A
- AVG Volume (30 Days)
- MSGM 13.0K
- BIAF 3.2M
- Earning Date
- MSGM 11-06-2025
- BIAF 11-14-2025
- Dividend Yield
- MSGM N/A
- BIAF N/A
- EPS Growth
- MSGM N/A
- BIAF N/A
- EPS
- MSGM 0.00
- BIAF N/A
- Revenue
- MSGM $8,127,065.00
- BIAF $7,681,059.00
- Revenue This Year
- MSGM $69.07
- BIAF N/A
- Revenue Next Year
- MSGM $30.56
- BIAF $20.04
- P/E Ratio
- MSGM $5.63
- BIAF N/A
- Revenue Growth
- MSGM N/A
- BIAF 4.99
- 52 Week Low
- MSGM $0.73
- BIAF $2.34
- 52 Week High
- MSGM $3.92
- BIAF $46.53
- Technical
- Relative Strength Index (RSI)
- MSGM 37.21
- BIAF 46.15
- Support Level
- MSGM $2.21
- BIAF $2.43
- Resistance Level
- MSGM $2.45
- BIAF $3.50
- Average True Range (ATR)
- MSGM 0.11
- BIAF 0.25
- MACD
- MSGM 0.01
- BIAF -0.07
- Stochastic Oscillator
- MSGM 31.90
- BIAF 8.70
About MSGM Motorsport Games Inc.
Motorsport Games Inc is a motorsport network company that combines engaging video games with esports competitions and content for racing fans and gamers around the globe. The company has its reportable segments into the development and publishing of interactive racing video games, entertainment content and services, and the organization and facilitation of esports tournaments, competitions, and events for licensed racing games as well as on behalf of third-party video game racing series and other video game publishers. The majority of the revenue is earned from Gaming.
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.